Items where Author is "Hill, Andrew"

Item Type No Grouping

Testing novel strategies for patients hospitalised with HIV-associated disseminated tuberculosis (NewStrat-TB):protocol for a randomised controlled trial. (2024) Namale, Phiona E.; Boloko, Linda; Vermeulen, Marcia; Haigh, Kate A.; Bagula, Fortuna; Maseko, Alexis; Sossen, Bianca; Lee-Jones, Scott; Msomi, Yoliswa; McIlleron, Helen; Mnguni, Ayanda Trevor; Crede, Thomas; Szymanski, Patryk; Naude, Jonathan; Ebrahim, Sakeena; Vallie, Yakoob; Moosa, Muhammed Shiraz; Bandeker, Ismail; Hoosain, Shakeel; Nicol, Mark P.; Samodien, Nazlee; Centner, Chad; Dowling, Wentzel; Denti, Paolo; Gumedze, Freedom; Little, Francesca; Parker, Arifa; Price, Brendon; Schietekat, Denzil; Simmons, Bryony; Hill, Andrew; Wilkinson, Robert J.; Oliphant, Ida; Hlungulu, Siphokazi; Apolisi, Ivy; Toleni, Monica; Asare, Zimkhitha; Mpalali, Mkanyiseli Kenneth; Boshoff, Erica; Prinsloo, Denise; Lakay, Francisco; Bekiswa, Abulele; Jackson, Amanda; Barnes, Ashleigh; Johnson, Ryan; Wasserman, Sean; Maartens, Gary; Barr, David; Schutz, Charlotte; Meintjes, Graeme picture_as_pdf

Risks of metabolic syndrome in the ADVANCE and NAMSAL trials. (2023) Tovar Sanchez, Tamara; Mpoudi-Etame, Mireille; Kouanfack, Charles; Delaporte, Eric; Calmy, Alexandra; Venter, Francois; Sokhela, Simiso; Bosch, Bronwyn; Akpomiemie, Godspower; Tembo, Angela; Pepperrell, Toby; Simmons, Bryony; Casas, Carmen Perez; McCann, Kaitlyn; Mirchandani, Manya; Hill, Andrew picture_as_pdf

Initial supplementary dose of Dolutegravir in second-line antiretroviral therapy:a noncomparative, double-blind, randomized placebo-controlled trial. (2023) Zhao, Ying; Griesel, Rulan; Omar, Zaayid; Simmons, Bryony; Hill, Andrew; van Zyl, Gert; Keene, Claire; Maartens, Gary; Meintjes, Graeme picture_as_pdf

Comparing prospective incident severe acute respiratory syndrome Coronavirus 2 infection rates during successive waves of Delta and Omicron in Johannesburg, South Africa. Sokhela, Simiso; Bosch, Bronwyn; Hill, Andrew; Simmons, Bryony; Woods, Joana; Johnstone, Hilary; Madhi, Shabir; Qavi, Ambar; Ellis, Leah; Akpomiemie, Godspower; Bhaskar, Esther; Levi, Jacob; Falconer, Jonathan; Mirchandani, Manya; Perez Casas, Carmen; Moller, Karlien; Pilkington, Victoria; Pepperrell, Toby; Venter, Willem Daniel Francois picture_as_pdf

Final 192-week efficacy and safety results of the ADVANCE trial, comparing 3 first-line antiretroviral regimens. Sokhela, Simiso; Venter, Willem D.F.; Bosch, Bronwyn; Woods, Joana; McCann, Kaitlyn; Akpomiemie, Godspower; Chandiwana, Nomathemba; Mashabane, Nkuli; Tembo, Angela; Simmons, Bryony; Lalla-Edward, Samanta; Siedner, Mark J.; Sinxadi, Phumla; Hermans, Lucas; Fairlie, Lee; Vos, Alinda; Abrams, Elaine; Manne-Goehler, Jennifer M.; Moorhouse, Michelle; Clayden, Polly; Norris, Shane; Qavi, Ambar; Chersich, Matthew; Masenya, Masebole; Arulappan, Natasha; Hill, Andrew picture_as_pdf

Low CD4 counts predict excessive weight gains during first-line treatment for HIV. Hill, Andrew; Tovar sanchez, Tamara; Delaporte, Eric; Sokhela, Simiso; Simmons, Bryony; Kouanfack, Charles; Mccann, Kaitlyn; Levi, Jacob; Fairhead, Cassandra; Venter, Francois picture_as_pdf

Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection. Sokhela, Simiso; Bosch, Bronwyn; Hill, Andrew; Simmons, Bryony; Woods, Joana; Johnstone, Hilary; Akpomiemie, Godspower; Ellis, Leah; Owen, Andrew; Casas, Carmen Perez; Venter, Willem Daniel Francois picture_as_pdf